课题基金 / 基金详情

A new model mice for human chronic myelogenous leukemia by the disruption of SPA-1 gene.

A new model mice for human chronic myelogenous leukemia by the disruption of SPA-1 gene.
通过破坏 SPA-1 基因建立人类慢性粒细胞白血病的新模型小鼠。
批准号:
15590337
负责人:
HATTORI Masakazu
金额:
$2.3万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004

项目摘要

项目成果

HATTORI Masakazu的其他基金

相似基金

相关文献

中文摘要
翻译
RAP1是Ras家族GTP酶家族的成员之一,根据细胞环境的不同,它在细胞增殖或细胞黏附的调节中起着重要的作用。在淋巴造血组织中,SPA-1是主要的Rap1 GTP酶激活蛋白。缺乏SPA-1基因的小鼠出现了T细胞免疫缺陷的年龄依赖性进展,随后出现了一系列迟发性骨髓增生性疾病,类似于人类慢性髓系白血病。在SPA-1缺陷小鼠中,RAP1的失控激活导致骨髓造血祖细胞的扩张增强,但导致T细胞进行性无反应或无能。因此,RAP1及其调节因子SPA-1可以为人类血液系统恶性肿瘤的控制提供独特的分子靶点。SPA-1缺乏还导致B1A细胞的年龄依赖性扩张,产生抗双链DNA和抗核抗体,从而导致狼疮样自身免疫。SPA-1缺陷小鼠骨髓B细胞前体细胞持续激活RAP1,通过激活控制V-κ基因重组的OCAB基因,导致V-κ基因库的明显偏向和广泛的“部分”受体编辑,从而导致致病的自身反应性B1细胞的产生。此外,SPA-1基因缺陷的小鼠经常发生B1细胞起源的白血病,同时产生溶血性自身抗体。结果表明,骨髓微环境对发育中B细胞抗原受体谱系的形成有明显的调节作用,RAP1信号在其中起重要作用。
英文摘要
Rap1 is a member of the Ras family of GTPases and, depending on the cellular context, has an important role in the regulation of proliferation or cell adhesion. In lympho-hematopoietic tissues, SPA-1 is a principal Rap1 GTPase-activating protein. Mice that were deficient for the SPA-1 gene developed age-dependent progression of T-cell immunodeficiency followed by a spectrum of late onset myeloproliferative disorders, mimicking human chronic myeloid leukemia. Deregulated Rap1 activation in SPA-1-deficient mice caused enhanced expansion of the bone marrow hematopoietic progenitors, but induced progressive unresponsiveness or anergy in T cells. Rap1 and its regulator, SPA-1, could, therefore, provide unique molecular targets for the control of human hematologic malignancy.SPA-1-deficiency also caused the age-dependent expansion of B1a cell producing anti-dsDNA and anti-nuclear antibodies in the peritoneal cavity resulting in lupus-like autoimmunity. Sustained Rap1 activation in the bone marrow B cell precursors in SPA-1-deficient mice induced markedly biased Vκ gene repertoire and extensive "partial" receptor editing by activating OcaB gene controlling Vκ gene recombination, thereby leading to the generation of pathogenic self-reactive B1 cells. Furthermore, SPA-1-deficient mice frequently developed leukemia preferentially of B1 cell origin along with hemolytic autoantibody production. The results suggest that antigen-receptor repertoire formation in developing B cells can be significantly modified by the stimuli from bone marrow microenvironment, in which Rap1-signal plays an important role.
期刊论文(35)
专著(0)
科研奖励(0)
会议论文
Harazaki, M., et al.: "Specific recruitment of SPA-1 to the immunological synapse : involvement of actin-bundling protein actinin"Immunology Letter. (In press). (2003)
Harazaki, M., et al.:“SPA-1 向免疫突触的特异性募集:肌动蛋白捆绑蛋白肌动蛋白的参与”免疫学快报。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Ishida, D., et al.: "Myeloproliferative stem cell disorders by deregulated Rap1 activation in SPA-1-deficient mice"Cancer Cell. 4. 55-65 (2003)
Ishida, D. 等人:“SPA-1 缺陷小鼠中 Rap1 激活失调导致骨髓增殖干细胞疾病”Cancer Cell。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
獣医微生物学 第2版
兽医微生物学第二版
DOI: --
发表时间: 2003
期刊:
影响因子: --
作者: [Fujimura S, Suzumiya J, (2番目他3名), 服部 雅一]
通讯作者: 服部 雅一
Hattori, M., Minato, N.: "Rap1 GTPase : functions, regulation, and malignancy"J.Biochem.. 134. 479-484 (2003)
Hattori, M., Minato, N.:“Rap1 GTPase:功能、调节和恶性”J.Biochem.. 134. 479-484 (2003)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
14
    Study on the mechanism(s) of immunosenescence and its application for vaccine development.
    • 批准号:
      26450443
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.33万
    • 财政年份:
      2014
    • 负责人:
      HATTORI Masakazu
    • 依托单位:
    MHC-linked type 1 diabetes genes in NOD mice
    Regulation of T-cell and antigen-presenting cell interactions by Rapl.
    • 批准号:
      12670300
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.24万
    • 财政年份:
      2000
    • 负责人:
      HATTORI Masakazu
    • 依托单位:
    Essential role of transcriptional regulator Hesl in the early development of T cells.
    • 批准号:
      10670300
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.11万
    • 财政年份:
      1998
    • 负责人:
      HATTORI Masakazu
    • 依托单位:
    国内基金
    海外基金
    SPA-1蛋白调控乳腺癌细胞浸润和转移分子机制研究
    • 批准号:
      31271504
    • 项目类别:
      面上项目
    • 资助金额:
      80.0万元
    • 批准年份:
      2012
    • 负责人:
      苏莉
    • 依托单位: